Very late-onset membranous nephropathy secondary to alemtuzumab in a patient with multiple sclerosis

Introduction We conducted a prevalence study of multiple sclerosis (MS) in the Spanish province of Zamora. Methods We conducted a retrospective cohort study of data on patients with multiple sclerosis under follow-up at the neurology […]

Introduction and objective Teriflunomide is an oral immunomodulatory agent approved for the treatment of relapsing–remitting multiple sclerosis (RRMS). We examined teriflunomide outcomes in patients with RRMS under clinical practice conditions in Spain. Material and methods […]

Introduction In recent years, there has been an increase of studies dedicated to cognitive rehabilitation in patients with multiple sclerosis (MS); however, few of these analyze the impact on such variables as cognitive reserve. The […]